Navigation Links
HMS Holdings Corp. to Present at 2008 UBS Global Healthcare Services Conference
Date:2/5/2008

NEW YORK, Feb. 5 /PRNewswire-FirstCall/ -- HMS Holdings Corp. (Nasdaq: HMSY) today announced that it will present at the 2008 UBS Global Healthcare Services Conference, which will be held February 11-13, 2008 at the Grand Hyatt in New York City.

Walter Hosp, Senior Vice President and Chief Financial Officer of HMS Holdings Corp., will present on Monday, February 11th at 8:30 a.m. Eastern Time.

A live broadcast of the Company's presentation can be accessed through our website at http://www.hmsholdings.com/news/presentations.asp. The replay of the presentation will begin three hours after the actual presentation time and will be available until March 14, 2008.

HMS Holdings Corp. (Nasdaq: HMSY) is the nation's leader in cost management, coordination of benefits, and program integrity services for government healthcare programs. HMS serves the Medicaid programs of 40 states, 72 Medicaid managed care plans, the Centers for Medicare and Medicaid Services (CMS), and Veterans Administration facilities. HMS helps ensure that healthcare claims are paid correctly and by the responsible party. As a result of the company's services, government healthcare programs recover over $1.0 billion annually, and obtain access to data that helps them prevent billions of dollars in erroneous payments.


'/>"/>
SOURCE HMS Holdings Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. NightHawk Radiology Holdings, Inc. Announces Date for Fourth Quarter and Full-Year 2007 Earnings Conference Call
2. Zimmer Holdings to Present at Merrill Lynch Health Care Conference
3. China Pharma Holdings, Inc. Receives Chinese SFDA Approval for Generic Bumetanide Injection
4. NightHawk Radiology Holdings, Inc. Announces Preliminary 2007 Results
5. Z Trim Holdings, Inc. Launches Innovative Retail Line of Lower Fat Salad Dressings in Upscale Grocery Chain
6. Batesville Holdings, Inc., Appoints Cynthia L. Lucchese Senior Vice President and Chief Financial Officer
7. Liberator Medical Holdings Exceeds December Sales
8. Zimmer Holdings Announces Webcast and Conference Call of Fourth Quarter and Full-Year 2007 Results
9. HearAtLast Holdings, Inc. Provides Shareholder Update
10. Lincare Holdings Inc. Reports Intention to File Shelf Registration Statement
11. HMS Holdings Corp. to Present at 26th Annual JPMorgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... ... June 23, 2017 , ... Radabaugh & Associates, a locally ... business owners in North Central West Virginia, is embarking on a cooperative charity ... residents in the region. , The Stepping Stones organization offers a series of ...
(Date:6/22/2017)... ... 2017 , ... Plastic Surgery Associates is proud to report that founding surgeon, ... research and information firm, Castle Connolly, releases their list of the most notable and ... 3rd time that Dr. Canales has been recognized by Castle Connolly. , ...
(Date:6/22/2017)... ... June 22, 2017 , ... ... from the American Heart Association (AHA) to launch a Rheumatic Heart Disease Center, ... prevention and diagnosis of rheumatic heart disease (RHD) in high-risk, financially disadvantaged countries ...
(Date:6/22/2017)... , ... June 22, 2017 , ... ... announced today that it has received certification for ANSI/ASIS PSC.1-2012. The company’s work ... in environments where the rule of law has been degraded. The PSC.1 standard ...
(Date:6/20/2017)... ... June 20, 2017 , ... TwelveStone Health Partners, ... a Nashville-based private equity firm, has invested $3.35 million in the company. ... and Claritas Capital offers the smart money, speed to market and accountability we ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... -- Endo International plc (NASDAQ: ENDP ) ... Joseph R. Goodwin , U.S. District Court Judge for ... , entered a case management order in MDL 2325, ... Litigation (the "MDL") that includes a provision requiring plaintiffs ... on specific causation within one hundred twenty (120) days ...
(Date:6/3/2017)... 2017  Eli Lilly and Company (NYSE: ... the Phase 3 MONARCH 2 study showed that ... in combination with fulvestrant, significantly improved progression-free survival ... women with hormone-receptor-positive (HR+), human epidermal growth factor ... relapsed or progressed after endocrine therapy (median PFS, ...
(Date:5/30/2017)... AVIV, Israel , May 30, 2017 ... stage pharmaceutical Company specializing in the development of ... will present a company overview at three upcoming ... The 7th Annual LD Micro Invitational: ... Date:                     ...
Breaking Medicine Technology: